Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

Sabine I. Braun; Gallus Bischof; Hans Jürgen Rumpf

doi:10.1016/j.addbeh.2011.12.002

Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

Sabine I. Braun^*, Gallus Bischof, Hans Jürgen Rumpf

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Psychiatrie und Psychotherapie

1 Zitat (Scopus)

Abstract

The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.

Originalsprache	Englisch
Zeitschrift	Addictive Behaviors
Jahrgang	37
Ausgabenummer	4
Seiten (von - bis)	444-448
Seitenumfang	5
ISSN	0306-4603
DOIs	https://doi.org/10.1016/j.addbeh.2011.12.002
Publikationsstatus	Veröffentlicht - 04.2012

Fördermittel

This study is part of the German research network EARLINT (EARLy substance use INTervention) and is funded by the German Federal Ministry of Health. The present analysis is part of the project MIMiK (grant no. 15 02/68661). The German Federal Ministry of Health had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen
SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Dokumente

10.1016/j.addbeh.2011.12.002

Weitere Links

Link to publication in Scopus

Zitieren

@article{99b7bf9aede847c88afba70d7521c88a,

title = "Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20",

abstract = "The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.",

author = "Braun, \{Sabine I.\} and Gallus Bischof and Rumpf, \{Hans J{\"u}rgen\}",

note = "Funding Information: This study is part of the German research network EARLINT (EARLy substance use INTervention) and is funded by the German Federal Ministry of Health. The present analysis is part of the project MIMiK (grant no. 15 02/68661). The German Federal Ministry of Health had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication. Copyright: Copyright 2012 Elsevier B.V., All rights reserved.",

year = "2012",

month = apr,

doi = "10.1016/j.addbeh.2011.12.002",

language = "English",

volume = "37",

pages = "444--448",

journal = "Addictive Behaviors",

issn = "0306-4603",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

AU - Braun, Sabine I.

AU - Bischof, Gallus

AU - Rumpf, Hans Jürgen

N1 - Funding Information: This study is part of the German research network EARLINT (EARLy substance use INTervention) and is funded by the German Federal Ministry of Health. The present analysis is part of the project MIMiK (grant no. 15 02/68661). The German Federal Ministry of Health had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication. Copyright: Copyright 2012 Elsevier B.V., All rights reserved.

PY - 2012/4

Y1 - 2012/4

N2 - The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.

AB - The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.

UR - https://www.scopus.com/pages/publications/84857055062

U2 - 10.1016/j.addbeh.2011.12.002

DO - 10.1016/j.addbeh.2011.12.002

M3 - Journal articles

C2 - 22209654

AN - SCOPUS:84857055062

SN - 0306-4603

VL - 37

SP - 444

EP - 448

JO - Addictive Behaviors

JF - Addictive Behaviors

IS - 4

ER -

Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

Abstract

Fördermittel

UN SDGs

Strategische Forschungsbereiche und Zentren

Dokumente

Weitere Links

Fingerprint

Zitieren